Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan

Headache

Volumn 46, Issue 7, 2006, Pages 1142-1150

  Goldstein, Jerome ^a   Tiseo, Paul T ^b   Albert, Kenneth S ^b   Li, Chunming ^b   Sikes, Carolyn R ^b  

^a San Francisco Headache Clinic   (United States)

^b NONE

Author keywords

Eletriptan; Headache; Migraine; Rizatriptan; Triptan

Indexed keywords

ELETRIPTAN; RIZATRIPTAN;

ADULT; ANALGESIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; FEMALE; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT SATISFACTION; PHOTOPHOBIA; PRIORITY JOURNAL; RECURRENT DISEASE; SOMNOLENCE; THORAX PAIN; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PYRROLIDINES; SEROTONIN AGONISTS; SEROTONIN RECEPTOR AGONISTS; TREATMENT FAILURE; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 33745629591     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00505.x     Document Type: Article

References (16)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ. 1996;312:71-72.
2. Mulder RT, Frampton C, Joyce PR, Porter R. Randomized controlled trials in psychiatry. Part II: Their relationship to clinical practice. Aust N Z J Psychiatry. 2003;37:265-269.
3. 1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet. 2001;358:1668-1675.
4. Ferrari MD, Loder E, McCarroll KA, Lines CR. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia. 2001;21:129-136.
5. Diener HC. Eletriptan in migraine. Expert Rev Neurother. 2005;5:43-53.
6. Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol. 2004;4:4.
7. Diamond ML, Hettiarachchi J, Hilliard B, Sands G, Nett R. Effectiveness of eletriptan in acute migraine: Primary care for Excedrin nonresponders. Headache. 2004;44:209-216.
8. Chia YC, Lim SH, Wang SJ, Cheong YM, Denaro J, Hettiarachchi J. Efficacy of eletriptan in migraineurs with persistent poor response to non-steroidal anti-inflammatory drugs. Headache. 2003;43:984-990.
9. Martin VT, Loder E, Taylor K, Almas M, Hilliard B. Eletriptan treatment of migraine in patients switching from Fiorinal® or Fioricet®: Results of a multiple-attack study. Cephalalgia (in press).
10. Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ. Eletriptan and Cafergot Comparative Study Group. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol. 2002;47:99-107.
11. Stark S, Spierings EL, McNeal S, Putnam GP, Bolden-Watson CP, O'Quinn S. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache. 2000;40:513-520.
12. Färkkilä M, Olesen J, Dahlöf C, et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia. 2003;23:463-471.
13. Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial. Headache. 2000;40:464-465.
14. Diener HC, Gendolla A, Gebert I, Beneke M. Almotriptan in migraine patients who respond poorly to oral sumatriptan: A double-blind, randomized trial. Eur Neurol. 2005;53(suppl 1):41-48.
15. Dodick DW. Triptan nonresponder studies: Implications for clinical practice. Headache. 2005;45:156-162.
16. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998;8(suppl 7):1-96.